The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans

Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance

(2017) Ruth C. R. Meex et al.   Nature Reviews Endocrinology

Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk

(2016) Jennifer H. Stern et al.   Cell Metabolism

Association of high fetuin-B concentrations in serum with fertilization rate in IVF: a cross-sectional pilot study

(2016) Julia Floehr et al.   HUMAN REPRODUCTION

PNPLA3 gene in liver diseases

(2016) Eric Trépo et al.   JOURNAL OF HEPATOLOGY

Phenotypes of prediabetes and stratification of cardiometabolic risk

(2016) Norbert Stefan et al.   Lancet Diabetes & Endocrinology

Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans

(2016) Elko Randrianarisoa et al.   Scientific Reports

Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism

(2015) Ruth C. Meex et al.   Cell Metabolism

Hepatokines: unlocking the multi-organ network in metabolic diseases

(2015) Alison Iroz et al.   DIABETOLOGIA

NAFLD: A multisystem disease

(2015) Christopher D. Byrne et al.   JOURNAL OF HEPATOLOGY

Lipoprotein subclass metabolism in nonalcoholic steatohepatitis

(2014) Ville T. Männistö et al.   JOURNAL OF LIPID RESEARCH

Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease

(2014) Gerald I. Shulman   NEW ENGLAND JOURNAL OF MEDICINE

Impact of the Adipokine Adiponectin and the Hepatokine Fetuin-A on the Development of Type 2 Diabetes: Prospective Cohort- and Cross-Sectional Phenotyping Studies

(2014) Norbert Stefan et al.   PLoS One

Genomic responses in mouse models greatly mimic human inflammatory diseases

(2014) Keizo Takao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial

(2014) Norbert Stefan et al.   Lancet Diabetes & Endocrinology

FGF19 action in the brain induces insulin-independent glucose lowering

(2013) Gregory J. Morton et al.   JOURNAL OF CLINICAL INVESTIGATION

Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans

(2013) Norbert Stefan et al.   NATURE MEDICINE

The role of hepatokines in metabolism

(2013) Norbert Stefan et al.   Nature Reviews Endocrinology

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

(2013) Quentin M. Anstee et al.   Nature Reviews Gastroenterology & Hepatology

Genomic responses in mouse models poorly mimic human inflammatory diseases

(2013) Junhee Seok et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Association of Fetuin-A With Incident Diabetes Mellitus in Community-Living Older Adults

(2012) Joachim H. Ix et al.   CIRCULATION

Plasma Levels of Fetuin-A and Hepatic Enzymes and Risk of Type 2 Diabetes in Women in the U.S.

(2012) Qi Sun et al.   DIABETES

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

(2012) Durba Pal et al.   NATURE MEDICINE

Muscles, exercise and obesity: skeletal muscle as a secretory organ

(2012) Bente K. Pedersen et al.   Nature Reviews Endocrinology

Simultaneous Measurement of Insulin Sensitivity, Insulin Secretion, and the Disposition Index in Conscious Unhandled Mice

(2012) Laura C. Alonso et al.   Obesity

Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies

(2011) John Willy Haukeland et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content

(2011) A Peter et al.   INTERNATIONAL JOURNAL OF OBESITY

Human Fatty Liver Disease: Old Questions and New Insights

(2011) J. C. Cohen et al.   SCIENCE

Relationships of Circulating Sex Hormone-Binding Globulin With Metabolic Traits in Humans

(2010) A. Peter et al.   DIABETES

Elevated Fetuin-A Concentrations in Morbid Obesity Decrease after Dramatic Weight Loss

(2010) Johanna Maria Brix et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Association of AHSG Gene Polymorphisms With Fetuin-A Plasma Levels and Cardiovascular Diseases in the EPIC-Potsdam Study

(2009) Eva Fisher et al.   Circulation-Cardiovascular Genetics

Individual Stearoyl-CoA Desaturase 1 Expression Modulates Endoplasmic Reticulum Stress and Inflammation in Human Myotubes and Is Associated With Skeletal Muscle Lipid Storage and Insulin Sensitivity In Vivo

(2009) A. Peter et al.   DIABETES

Type 3 cystatins; fetuins, kininogen and histidine-rich glycoprotein

(2009) Chunsik Lee   Frontiers in Bioscience-Landmark

An oestrogen-receptor-α-bound human chromatin interactome

(2009) Melissa J. Fullwood et al.   NATURE

Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke

(2008) Cornelia Weikert et al.   CIRCULATION

Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes

(2008) N. Stefan et al.   DIABETES

Fetuin-A and Its Relation to Metabolic Syndrome and Fatty Liver Disease in Obese Children Before and After Weight Loss

(2008) Thomas Reinehr et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM